PRL3-ZUMAB
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for PRL3-ZUMAB, covering 2025-06-11 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: PRL3-Zumab in Patients With Advanced Solid Tumors [Phase 2]